The Neglected Side of Parkinson's Disease
The content you've requested is available without charge only to active Sigma Xi members and affiliates.
If you are an active member, affiliate or individual subscriber, please log in now in order to access this article. Be sure you've entered your member or subscriber number on your profile page. (You can access your profile page through the green box to the right.)
If you are not a member, affiliate or individual subscriber, you can:
For decades, biomedical researchers have understood that such classic symptoms of Parkinson's disease as shaking and slowness of movement result from the death of nerve cells that use the neurotransmitter dopamine to communicate. Treatments that boost the level of dopamine in the brain have helped millions of patients. But there are symptoms that do not respond to such therapy. The nondopaminergic features of Parkinson's disease include some of the most devastating, including a tendency to experience injurious falls and the development of dementia. Study of the nondopaminergic side of Parkinson's disease is of keen importance, and the results of such efforts may one day provide strategies for combating all aspects of this debilitating illness.